Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk

(MedPage Today) -- The FDA approved olezarsen (Tryngolza) to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia, the agency announced on Wednesday.
Olezarsen, an mRNA-targeted antisense oligonucleotide...